The role of armed forces in disaster management is a crucial one, as they are often called upon to provide assistance and support in times of crisis. Whether it is a natural disaster, such as a hurricane or earthquake, or a man-made disaster, such as a terrorist attack, the armed forces are trained and equipped to handle a wide range of situations.
One of the primary roles of the armed forces in disaster management is to provide rescue and recovery efforts. This may involve airlifting stranded individuals to safety, providing medical care to those who are injured, and clearing debris to make roads and other infrastructure passable again. The armed forces also play a key role in providing logistical support, such as setting up temporary shelters, distributing food and water, and coordinating with other agencies to ensure that aid is delivered efficiently.
In addition to rescue and recovery efforts, the armed forces may also be called upon to provide security and maintain order in the wake of a disaster. This may involve patrolling affected areas, setting up roadblocks and checkpoints, and working with local law enforcement to ensure the safety of affected communities.
Another important role of the armed forces in disaster management is to provide intelligence and communication support. This may involve gathering and analyzing information about the disaster, as well as maintaining and repairing communication systems that have been damaged or disrupted.
Finally, the armed forces may also be called upon to provide long-term support and reconstruction efforts following a disaster. This may involve rebuilding infrastructure, such as roads, bridges, and buildings, as well as providing technical assistance to local communities as they recover and rebuild.
In conclusion, the role of the armed forces in disaster management is critical, as they provide a range of essential services and support in times of crisis. Whether it is providing rescue and recovery efforts, maintaining security and order, gathering and analyzing intelligence, or providing long-term reconstruction support, the armed forces play a vital role in ensuring the safety and well-being of affected communities.
Engadget is part of the Yahoo family of brands
National Library of Medicine via the Annals of Thoracic Oncology. The device is intended to be used as a monotherapy, and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted. In the United States, Optune is intended as a treatment for adult patients 22 years of age or older with histologically-confirmed glioblastoma multiforme GBM. The study included 80 participants, all of whom received chemotherapy in addition to wearing the device. In the United States, Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery and completion of radiation therapy together with concomitant standard of care chemotherapy.
Optune Lua (Tumor Treating Fields) for Mesothelioma
Disruption of cancer cell replication by alternating electric fields. On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Do not use any parts that do not come with the Optune Treatment Kit, or that were not sent to you by the device manufacturer or given to you by your doctor. Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. Upon placement of the insulated electrodes of the NovoTTF-100A device on the skin's surface encircling the tumor area, electrical charges are delivered, and the resulting electrical fields interfere with cell division. Proc Natl Acad Sci U S A. More than 100 hospitals offer the therapy for unresectable malignant mesothelioma cases.
You can even sleep with it running. Optune for GBM and Optune Lua for MPM are not for everyone. What is Optune ® approved to treat? Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones. Either cell wall is where pleural mesothelioma forms. Mesothelioma affects between 2,500 and 3,000 each year. You are currently leaving Optune. Forward-Looking Statements In addition to historical facts or statements of current condition, this press release may contain forward-looking statements.
This is an improvement from the general survival time of 19 months. It is not known if Optune is safe or effective in these populations. What Are Tumor Treating Fields? Study Summary This is a non-randomized, concurrent control study, designed to confirm that the efficacy of the NovoTTF-100A System in patients with recurrent GBM treated in a real life settings following approval is comparable to that of BSC chemotherapy patients. Retrieved from: About the Writer, Devin Golden is the content writer for Mesothelioma Guide. Weinberg said to Mesothelioma Guide. Mesothelial cells turn cancerous when sharp By preventing mesothelioma cells from dividing, tumor treating fields halt the spread of this cancer.
Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Brand Name Change to Optune Lua NovoTTF-100L for pleural mesothelioma received a name change in March of 2020. The device was originally called NovoTTF-100L System. We are dedicated to making Optune available to all GBM patients who can benefit from our therapy in Japan. Any forward-looking statements herein speak only as of the date hereof. She has a deep passion for patient care, which includes helping patients and their families search for treatment options at the top mesothelioma cancer centers.
The Optune Lua device received FDA approval due to its excellent survival results in the phase 2 STELLAR clinical trial. Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. This result also was an improvement, of a couple months, compared to overall mesothelioma survival times. In this case, skin contact with the gel used with Optune may commonly cause increased redness and itching, and rarely may even lead to severe allergic reactions such as shock and respiratory failure. Food and Drug Administration approved a tumor treating fields device in May 2019.
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. In no event shall Novocure be liable to you or anyone else for any actions taken by you in reliance on the information contained in the "Find a Treatment Center" directory. Do not use Optune if you are known to be sensitive to conductive hydrogels. Securities and Exchange Commission. Benefits of Optune Lua for Pleural Mesothelioma One of the main benefits of tumor treating fields is the little-to-no downside of this therapy. It is now called Optune Lua.
Headquartered in Jersey, Novocure has U. Epithelioid mesothelioma patients averaged a survival time of close to 21 months. This membrane is made up of two cell walls, called the parietal pleura and visceral pleura. Use of Optune together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune ineffective. Epub 2012 May 18. Tumor treating fields disrupt cell division, which is the process mesothelioma cells use to duplicate and spread in your body. Do not wet the device or transducer arrays.
It received approval after outperforming chemotherapy in mesothelioma clinical trials. Karen Ritter, a registered nurse, is the lead patient advocate for Mesothelioma Guide. Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma MPM to be used together with standard chemotherapy pemetrexed and platinum-based chemotherapy. This most describes a stage 3 or stage 4 disease, which has a survival time of between a few months to a little more than one year. Epub 2007 Jun 5.